|
A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer Clinical research trials and A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer. A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer clinical trial. Test subjects typically receive the most expert healthcare available for their A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer  A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer
A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer
For Condition: Carcinoma, Non-Small-Cell Lung
Status: Recruiting
Sponsor(s): Eli Lilly and Company ,
Synopsis: The purpose of this study is to determine the effectiveness and side effects of LY293111 given in combination with gemcitabine and cisplatin in patients with non-small cell lung cancer.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Non-Small Cell Lung Cancer, Stage IIIB or IV that is not amenable to either surgery of curative intent or radiation therapy - Tumor that can be measured by x-ray or scan - Adequate organ function Exclusion Criteria: - Inability to swallow capsules - Documented brain metastases - Prior chemotherapy or biological therapy for this disease
Total Enrollment:
Location and Contact Information:
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Hamburg, ,
Germany
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Oviedo, Asturias,
Spain
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. *Recruiting*
Amsterdam, ,
Netherlands
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Pamplona, Navarra,
Spain
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. *Recruiting*
Gauting, ,
Germany
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Boston, Massachusetts,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. *Recruiting*
Rotterdam, ,
Netherlands
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Birmingham, Alabama,
United States
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Madrid, ,
Spain
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. *Recruiting*
Kfar Saba, ,
Israel
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Toronto, Ontario,
Canada
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Badalona, Barcelona,
Spain
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Manhasset, New York,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. *Recruiting*
Haifa, ,
Israel
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Montreal, Quebec,
Canada
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Durham, North Carolina,
United States
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Ottawa, Ontario,
Canada
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician". *Recruiting*
Houston, Texas,
United States
Recruiting
Additional Information:
Study ID Numbers: 4842;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00069875
Other Carcinoma, Non-Small-Cell Lung Studies:
1. Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer
2. Erlotinib in Treating Patients with Advanced Non-Small Cell Lung Cancer
3. Vaccine Treatment for Advanced Non-Small Cell Lung Cancer
4. OSI-774 (Tarceva) in Treating Patients with Stage III or Stage IV Non-Small Cell Lung Cancer
5. Temozolomide for Treatment of Brain Metastases from Non-Small Cell Lung Cancer
Related Studies:
Other Carcinoma, Non-Small-Cell Lung Clinical Trials
Other New York Clinical Trials
Other Manhasset Clinical Trials
A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer
|
|
|
|
|
|
|
|
